Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid management products for the treatment of acute and chr…
$1.43-8.33%
报价 2026-11-13
市值
$10.1M
EV
$187.3M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -93.6%
$1.43$22.51
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| SCLXScilex Holding Company | $10.1M | -8.3% | +75.5% | 55% | – | – | – | |
| ALECAlector, Inc. | $378.1M | +3.7% | +934.9% | 100% | – | – | – | |
| IRDOpus Genetics, Inc. | $331.1M | -2.0% | -4.4% | 99.9% | – | – | – | |
| AGENAgenus Inc. | $304.5M | -2.0% | +13.6% | 76.5% | 9.7x | 3.4x | – | |
| INOInovio Pharmaceuticals, Inc. | $98.8M | -2.1% | +10800.0% | 0% | – | – | – | |
| SEERSeer, Inc. | $87.6M | -1.3% | -4.1% | 47% | – | – | – | |
| LUCDLucid Diagnostics Inc. | $87.4M | +7.9% | +60.9% | -25.8% | – | – | – | |
| CTORCitius Oncology, Inc. | $53.4M | +9.9% | +205.7% | 53.1% | – | – | – | |
| IXHLIncannex Healthcare Limited | $23.6M | -2.5% | – | -192.7% | – | – | – | |
| 同行中位数 | – | – | +60.9% | 50.1% | 9.7x | 3.4x | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据(首次研究运行后填充)。